CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus. (Q55066852)
Jump to navigation
Jump to search
scientific article published in January 1997
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus. |
scientific article published in January 1997 |
Statements
CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus. (English)
1 reference
H Donner
1 reference
H Rau
1 reference
P G Walfish
1 reference
J Braun
1 reference
T Siegmund
1 reference
R Finke
1 reference
J Herwig
1 reference
K H Usadel
1 reference
K Badenhoop
1 reference
1 January 1997
1 reference
82
1 reference
1
1 reference
143-146
1 reference